Correction: Immune-related adverse events associated with nab-paclitaxel/paclitaxel combined with immune checkpoint inhibitors: a systematic review and network meta-analysis
Wenjing Hao, Jun Zhang, Yunxia Wang, Boyu Fang, Shasha Jin, Jing Yuan, Weimin Cai
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
- —National Natural Science Foundation of China10.13039/501100001809
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Immunotherapy and Biomarkers · Cancer Treatment and Pharmacology · Chemotherapy-related skin toxicity
In the published article, there was an error in the Funding statement. “This work was supported by grant from the National Natural Science Foundation of China [Grant No. 8217130423]”.
The correct Funding statement appears below.
“This work was supported by grant from the National Natural Science Foundation of China [Grant No. 82173892]“
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
The original article has been updated.